ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Retrospective Study |
Article Title |
Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tsutomu Nishida, Aya Sugimoto, Ryo Tomita, Yu Higaki, Naoto Osugi, Kei Takahashi, Kaori Mukai, Tokuhiro Matsubara, Dai Nakamatsu, Shiro Hayashi, Masashi Yamamoto, Sachiko Nakajima, Koji Fukui and Masami Inada |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Tsutomu Nishida, MD, PhD, Doctor, Doctor, Department of Gastroenterology, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, Osaka 560-8565, Japan. tnishida.gastro@gmail.com |
Key Words |
Advanced gastric cancer; Waiting time; Chemotherapy; Prognosis; Overall survival |
Core Tip |
Generally, most patients with advanced cancer have various additional conditions that are due to the advanced cancer, unlike patients who are candidates for surgery. It is currently unclear whether a delay in the initiation of chemotherapy in patients with advanced gastric cancer (A-GC) leads to adverse outcomes. In the present study, we evaluated the impact of treatment delay on clinical outcomes in patients with A-GC. Using propensity score matched analysis to minimize potential selection bias, we found that there was no significant difference in overall survival between patients in the early waiting time (WT) and elective WT groups. A longer WT in patients with A-GC does not appear to be associated with a worse prognosis. |
Publish Date |
2019-01-15 08:49 |
Citation |
Nishida N, Sugimoto A, Tomita R, Higaki Y, Osugi N, Takahashi K, Mukai K, Matsubara T, Nakamatsu D, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M. Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors. World J Gastrointest Oncol 2019; 11(1): 28-38 |
URL |
https://www.wjgnet.com/1948-5204/full/v11/i1/28.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v11.i1.28 |